Print Page
1805:
Biologics and Biomarkers for Asthma, Chronic Urticaria and Nasal Polyposis
Immune Mechanisms
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 3, S320CD
1.25 CME/CE
Symposium
Primary Moderators:
Paula J. Busse, MD FAAAAI
Gilda Varricchi

Learning Objectives:
  1. Describe biomarkers to characterize the phenotype and endotype of asthma, chronic urticaria and nasal polyposis
  2. Discuss the results of key clinical trials using biologics for asthma, chronic urticaria and nasal polyposis
  3. Describe the role of biomarkers in choosing patients for biologic therapies
4:00 PM
Precision Biologic Therapy for Severe Asthma
Thomas B. Casale, MD FAAAAI
Handouts
  • Precision Biologic Therapy for Severe Asthma.pdf (250.8 kB)
    • 4:20 PM
    Question & Answer
    4:25 PM
    Utility of Biologics for Antihistamine-Resistant Chronic Spontaneous Urticaria
    Marcus Maurer, MD
    4:45 PM
    Question & Answer
    4:50 PM
    Biologics for Nasal Polyposis
    Claus Bachert, MD PhD
    5:10 PM
    Question & Answer
    See more of: Session
    << Previous Session | Next Session >>